# CareDx (CDNA) — Earnings

CDNA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cdna/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.37 |
| EPS estimate | $0.23 |
| EPS surprise | +59.41% |
| Revenue surprise | +15.92% |
| Revenue | $131.9M |
| Revenue estimate | $113.8M |
| Reported | Jul 30, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1217234/000121723426000046/cdna-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/08467952-50e4-e691-95a0-13af23687146.html) |

CareDx reported Q2 2026 results on July 30, 2026. Earnings per share were $0.37, beating the $0.23 estimate by 59.41%. Revenue of $131.9 million topped the $113.8 million consensus by about 16%. In Q2 2025 CareDx lost $0.16 per share, so the result swung to a profit, and revenue rose about 52% from $86.7 million.

CareDx lost money in 15 of the 20 quarters in the table, including every quarter from Q3 2021 to Q3 2024. Q4 2024 was an exception at $1.51 per share, the high in the table, and the last four quarters were all profitable. Annual EPS was a loss of $1.44 in 2022 and $3.54 in 2023, a profit of $1.02 in 2024 and a loss of $0.20 in 2025. Annual revenue dipped to $280.4 million in 2023, then grew 19% in 2024 and 14% in 2025. CareDx beat the EPS estimate in each of the last four quarters and in 12 of the last 20.

Q3 reports came between October 28 and November 8 in each of the past five years. That points to early November 2026 for the next report. It will show whether the run of profitable quarters continues.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Jul 30, 2026 | $0.23 | $0.37 | 59.41% | $113.8M | $131.9M |
| Q1 2026 | Apr 28, 2026 | $0.13 | $0.34 | 154.68% | $102.0M | $117.7M |
| Q4 2025 | Feb 24, 2026 | $0.02 | $0.12 | 503.02% | $103.3M | $108.4M |
| Q3 2025 | Nov 4, 2025 | −$0.08 | $0.03 | 136.63% | $95.4M | $100.1M |
| Q2 2025 | Aug 6, 2025 | −$0.10 | −$0.16 | -65.98% | $90.6M | $86.7M |
| Q1 2025 | Apr 30, 2025 | −$0.21 | −$0.19 | 8.08% | $84.4M | $84.7M |
| Q4 2024 | Feb 26, 2025 | −$0.41 | $1.51 | 469.92% | $84.1M | $86.6M |
| Q3 2024 | Nov 4, 2024 | −$0.25 | −$0.14 | 43.14% | $80.0M | $82.9M |
| Q2 2024 | Jul 31, 2024 | −$0.40 | −$0.03 | 92.48% | $67.9M | $92.3M |
| Q1 2024 | May 9, 2024 | −$0.47 | −$0.32 | 32.42% | $63.1M | $72.0M |
| Q4 2023 | Feb 28, 2024 | −$0.45 | −$2.21 | -394.74% | $63.7M | $65.6M |
| Q3 2023 | Nov 8, 2023 | −$0.59 | −$0.43 | 26.91% | $53.1M | $67.2M |
| Q2 2023 | Aug 8, 2023 | −$0.54 | −$0.46 | 15.53% | $61.8M | $70.3M |
| Q1 2023 | May 10, 2023 | −$0.32 | −$0.44 | -36.31% | $80.7M | $77.3M |
| Q4 2022 | Feb 27, 2023 | −$0.33 | −$0.34 | -1.86% | $81.7M | $82.4M |
| Q3 2022 | Nov 3, 2022 | −$0.39 | −$0.32 | 18.37% | $82.6M | $79.4M |
| Q2 2022 | Aug 4, 2022 | −$0.34 | −$0.41 | -20.59% | $81.9M | $80.6M |
| Q1 2022 | May 5, 2022 | −$0.28 | −$0.37 | -34.55% | $78.9M | $79.4M |
| Q4 2021 | Feb 24, 2022 | −$0.14 | −$0.31 | -124.64% | $77.0M | $79.2M |
| Q3 2021 | Oct 28, 2021 | −$0.14 | −$0.23 | -67.27% | $74.1M | $75.6M |

## Frequently Asked Questions

### When did CareDx (CDNA) last report earnings?

CareDx last reported on Jul 30, 2026, covering fiscal Q2 2026.

### Did CDNA beat earnings estimates?

Yes. CareDx reported EPS of $0.37 for Q2 2026 against a $0.23 estimate — a 59.41% beat.

### How much revenue did CDNA report last quarter?

CareDx reported $131.9M in revenue for Q2 2026, against a consensus estimate of $113.8M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).